Watchlist Price Alert

NovoCure Limited (NVCR)

NASDAQ: NVCR · Real-Time Price · USD

17.89

0.34 (1.94%)

At close: Jun 16, 2025, 3:59 PM

17.91

0.08%

After-hours: Jun 16, 2025, 06:00 PM EDT

NovoCure Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	605.22M	509.34M	537.84M	535.03M	494.37M	351.32M	248.07M	177.03M	82.89M
Cost of Revenue	137.18M	128.28M	114.87M	114.88M	106.5M	88.61M	80.05M	55.61M	46.28M
Gross Profit	468.04M	381.06M	422.97M	420.15M	387.87M	262.71M	168.02M	121.42M	36.61M
Operating Income	-170.5M	-232.87M	-89.52M	-44.33M	21.25M	-914K	-33.67M	-39.33M	-115.32M
Interest Income	51M	46.04M	10.96M	791K	1.79M	4.4M	2.65M	1.12M	659K
Pretax Income	-131.16M	-191.74M	-81.85M	-52.08M	18.1M	-8.82M	-45.94M	-48.5M	-121.46M
Net Income	-168.63M	-207.04M	-92.53M	-58.35M	19.81M	-7.23M	-63.56M	-61.66M	-131.84M
Selling & General & Admin	428.89M	390.87M	306.41M	263.18M	225.45M	184.62M	151.12M	122.64M	110.46M
Research & Development	209.65M	223.06M	206.09M	201.3M	132.01M	79M	50.57M	38.1M	41.47M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	638.53M	614.67M	512.5M	464.49M	357.46M	263.63M	201.69M	160.75M	151.92M
Interest Expense	10.34M	3.32M	3.33M	3.44M	13.15M	13.72M	13.49M	10.26M	5.94M
Selling & Marketing Expenses	239.06M	226.81M	173.66M	137.06M	118.02M	96.67M	77.66M	63.53M	59.45M
Cost & Expenses	775.72M	742.21M	627.36M	579.36M	463.96M	352.23M	281.74M	216.35M	198.21M
Income Tax Expense	37.47M	15.3M	10.69M	6.28M	-1.71M	-1.59M	17.62M	13.16M	10.38M
Shares Outstanding (Basic)	107.83M	106.39M	104.66M	103.43M	100.93M	97.24M	91.83M	88.55M	85.56M
Shares Outstanding (Diluted)	107.83M	106.39M	104.66M	103.43M	108.88M	97.24M	91.83M	88.55M	85.56M
EPS (Basic)	-1.56	-1.95	-0.88	-0.56	0.20	-0.07	-0.69	-0.7	-1.54
EPS (Diluted)	-1.56	-1.95	-0.88	-0.56	0.18	-0.07	-0.69	-0.7	-1.54
EBITDA	-108.26M	-175.87M	-63.11M	-38.38M	45.3M	14.21M	-23.45M	-29.13M	-108.89M
EBIT	-120.82M	-188.42M	-78.51M	-48.63M	35.68M	5.05M	-32.45M	-38.24M	-114.54M
Depreciation & Amortization	11.23M	10.97M	10.62M	10.25M	9.15M	8.39M	9.01M	7.68M	5.65M